Theriva Biologics holds annual shareholder meeting

• Theriva Biologics held its annual shareholder meeting on Aug. 3, 2026.
• Shareholders backed a change to the 2020 Stock Incentive Plan, raising the share pool to 6,500,000 from 4,500,000.
• An amendment to increase authorized common shares cleared; the board can still choose whether to file the charter amendment.
• Investors ratified BDO USA as independent auditor for the year ending Dec. 31, 2026.
• Holders also authorized common share issuance on warrant exercise, while a contingency proposal to adjourn the meeting was approved but not used.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Theriva Biologics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-26-090064), on August 04, 2026, and is solely responsible for the information contained therein.